ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Jay Luly on Q1 2021 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2021 Earnings Conference Call February 08, 2021 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President & Chief Executive Officer Paul Mellett - Chief Financial Officer Conference Call Participants Roy Buchanan - JMP Securities Rachel Vatnsdal - Piper Sandler Brian Skorney - Baird Brian Abrahams - RBC Capital Markets Jay Olson - Oppenheimer Liisa Bayko - Evercore ISI Eric Joseph - JPMorgan Zegbeh Jallah - ROTH Capital Partners Akash Tewari - Wolfe Research Presentation Operator Good afternoon and welcome to Enanta Pharmaceutical's First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the conference over to Jennifer Viera Investor Relations. Please go ahead. Jennifer Viera
For further details see:
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q1 2021 Results - Earnings Call Transcript